-
Jazz Pharmaceuticals Analysis Reveals THC And CBD Therapy Alleviates MS Spasticity
Thursday, May 25, 2023 - 11:15pm | 497Read More...Treatment with the cannabis-based oral spray Nabiximols has been found to significantly relieve spasticity, a common symptom of multiple sclerosis (MS), according to a new analysis of two MS clinical trials. Spasticity is characterized by increased muscle stiffness and spasms, which can be...
-
Jazz Pharmaceuticals Announces Q3 2022 Financial Results, Raises Total Revenue Guidance
Thursday, November 10, 2022 - 10:07am | 569Read More...Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results late Wednesday for the third quarter of 2022 and raised the mid-point of 2022 total revenue guidance. "Our execution across our business continues to chart a clear path to delivering on Vision 2025. We have...
-
Celator Surges 70% After Acquisition Announcement By Jazz Pharmaceuticals
Tuesday, May 31, 2016 - 8:28am | 364Read More...Shares of Celator Pharmaceuticals Inc (NASDAQ: CPXX) surged higher by more than 70 percent early Tuesday morning after the company has agreed to be acquired by Jazz Pharmaceuticals plc (NASDAQ: JAZZ) for approximately $1.5 billion, or $30.25 per share. Celator's stock closed for trading at...
-
How Much Further Can Jazz Pharmaceuticals Fall?
Wednesday, April 8, 2015 - 4:40pm | 390Read More...The S&P 500 is currently coiling within a common chart pattern known as a triangle. The index isn’t really going up, not really going down. At some point the S&P will break out of that triangle. Some industries are performing well in that coiling-type environment, while others are...
-
Dow Flirts With 19,000, S&P 500 Approaches 2,000 & NASDAQ Trading At 14-Year Highs
Tuesday, August 19, 2014 - 4:35pm | 2619Read More...U.S. stocks rose as geopolitical events took a back seat and investors found positives in housing and consumer price index data released Tuesday. The markets followed the lead of Apple which closed at an all-time split-adjusted high of $100.53. Earnings from Home Depot and TJX Companies also...
-
Market Wrap For April 17: Mixed Earnings Drag The Dow Lower While S&P 500 & Nasdaq End Positive
Thursday, April 17, 2014 - 4:42pm | 2645Read More...U.S. stocks were mostly higher on Thursday as both the S&P 500 index and Nasdaq index recorded a fourth straight winning session in a relatively slow news day that was heavy on earnings. The Dow Jones rose as much as 35 points and falling as much as 56 as earnings from Dow listed companies...
-
Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy
Monday, March 31, 2014 - 4:37pm | 2097Read More...U.S. stocks rose in the final day of the first quarter as the Fed's boss Janet Yellen said there is still room for the central bank to further boost the economy. Yellen, speaking in Chicago today, said the scars from the Great Recession remain, and reaching our goals will take time." Yellen...
-
Market Wrap For March 28: Markets Still Positive Despite Giving Up Early Gains
Friday, March 28, 2014 - 4:27pm | 1778Read More...U.S. stocks finished the week on a positive note despite a sell-off in the afternoon. One possible reason for the sell-off is that investors are adjusting their portfolios for the end of the quarter on Monday. Major indices rallied off the opening bell with the Dow Jones Industrial Average...
-
Market Wrap For March 7: Markets Cap Off Positive Week With Small Gains
Friday, March 7, 2014 - 5:31pm | 2369Read More...U.S. stocks were mixed as investors continue to follow the standoff in Ukraine and digested February's jobs report which indicated that harsh winter weather could be the culprit behind weakness seen in recent economic data reports. The S&P 500 trading at new all time highs at 1,883.57 but...
-
Market Wrap For December 20: Markets Gain On GDP Data
Friday, December 20, 2013 - 5:44pm | 1875Read More...Major indices received a boost in Friday's trading activity following a better than expected third quarter GDP. The surprising economic data is yet another key data that may suggests that the economy is healthy enough and could handle the Fed's recent decision to taper its bond buying program....
-
Market Wrap For December 16: Dow Posts Triple Point Gain Ahead of Fed Meeting
Monday, December 16, 2013 - 5:55pm | 2347Read More...U.S stocks started off the week on a positive note with triple digit point gains for the Dow following one of the worst weeks in recent memory. Tuesday is an important day for the markets as the Fed begins its policy meeting which will last until Wednesday. After weeks of anticipating when (or...
-
Earnings Expectations For The Week Of November 4: Disney, Tesla, Groupon And More
Sunday, November 3, 2013 - 5:32pm | 1342Read More...While many S&P 500 components have already shared their third-quarter results, there will be plenty more earnings reports for investors to mull over this week. The week's highlights include quarterly reports from media giants CBS, Disney and Time Warner, which all are expect to post earnings...
-
Best Biotech Stocks of 2011
Tuesday, December 27, 2011 - 11:39am | 830Read More...Here's a quick look at nine of the best-performing biotech stocks of the past year. Achillion Pharmaceuticals (NASDAQ: ACHN) is up almost 88% year to date and about 37% higher just in the past month. This Connecticut-based biopharmaceutical company has three drugs in clinical trials to treat...
-
Piper Jaffray: Jazz Pharmaceuticals Not Expecting Payer Pushback In Wake Of Price Hike
Thursday, September 1, 2011 - 9:58am | 160Read More...Piper Jaffray released a research report on Jazz Pharmaceuticals (NASDAQ: JAZZ) announcing they are not expecting payer pushback in the wake of most recent Xyrem price hike. In its report, Jazz Pharmaceuticals writes that, “Beginning today, Jazz is implementing a near 20% price increase for...












